Cryoport Closes at $18.67, Down 2.10% from Previous Day’s Closing Price
June 22, 2023
🌥️Trending News
Cryoport ($NASDAQ:CYRX) Inc. had a rough day on the stock market yesterday, closing at $18.67, down 2.10% from the previous day’s closing price of $19.07. Cryoport Inc. is a biostorage and logistics provider for temperature-controlled solutions for the life sciences industry. The company is based in Irvine, California and focuses on providing specialized cold chain logistics solutions to its customers. The company’s services include frozen and refrigerated transport, as well as storage for cryogenic and ambient temperatures.
Analysis
We at GoodWhale have conducted an analysis of CRYOPORT‘s wellbeing. Based on our Risk Rating, we have found that CRYOPORT is a high risk investment in terms of both financial and business aspects. We have detected three risk warnings in the income sheet, balance sheet, and cashflow statement. If you would like to explore further into the risk associated with investing in CRYOPORT, please register on our website at goodwhale.com. Our analysis team is ready and waiting to assist you in understanding all the relevant information and helping you make an informed decision. More…
About the Company
Income Snapshot
Below shows the total revenue, net income and net margin for Cryoport. More…
| Total Revenues | Net Income | Net Margin |
| 247.79 | -37.5 | -14.2% |
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for Cryoport. More…
| Operations | Investing | Financing |
| 0.4 | -64.11 | -31.05 |
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for Cryoport. More…
| Total Assets | Total Liabilities | Book Value Per Share |
| 1.05k | 487.59 | 11.56 |
Key Ratios Snapshot
Some of the financial key ratios for Cryoport are shown below. More…
| 3Y Rev Growth | 3Y Operating Profit Growth | Operating Margin |
| 88.4% | – | -8.5% |
| FCF Margin | ROE | ROA |
| -11.9% | -2.3% | -1.2% |
Peers
In the logistics and transportation industry, there is intense competition among companies to provide the most efficient and cost-effective services. This is especially true for companies specializing in cryogenic transportation, where time and temperature sensitive shipments are the norm. In this arena, CryoPort Inc. has been a leader, innovating and investing in cutting-edge technology to stay ahead of the competition. Some of its main competitors include Shenzhen Prolto Supply Chain Management Co Ltd, Xinjiang Tianshun Supply Chain Co Ltd, and BEST Inc. While each company has its own strengths and weaknesses, CryoPort has consistently remained at the forefront of the industry, providing superior service and value to its customers.
– Shenzhen Prolto Supply Chain Management Co Ltd ($SZSE:002769)
Shenzhen Prolto Supply Chain Management Co Ltd has a market cap of 3.23B as of 2022, and a Return on Equity of 2.47%. The company is engaged in the business of providing supply chain management services. It offers services such as logistics, transportation, warehousing, and distribution. The company has a network of over 1,000 warehouses in China.
– Xinjiang Tianshun Supply Chain Co Ltd ($SZSE:002800)
Xinjiang Tianshun Supply Chain Co Ltd is a Chinese company that operates in the logistics and supply chain management industry. The company has a market capitalization of 2.2 billion US dollars as of 2022 and a return on equity of 6.85 percent. Xinjiang Tianshun Supply Chain Co Ltd is headquartered in the city of Urumqi in the Xinjiang Uyghur Autonomous Region of China. The company was founded in the year 2006.
– BEST Inc ($NYSE:BEST)
BEST Inc. is a leading express delivery and logistics company in China, with a market cap of $49.1 million as of 2022. The company has a return on equity of -60.92%. BEST Inc. provides express delivery, warehousing, and logistics services in China. The company operates a network of over 30,000 stores and more than 200 warehouses across China.
Summary
Cryoport Inc. is a logistics company that specializes in transporting temperature-sensitive life sciences materials. Its stock price has seen a decrease of 2.10% in the last session, closing at $18.67. Investors should consider several factors when analyzing Cryoport as an investment. Firstly, Cryoport’s well-established logistics services give it a strong competitive advantage in the industry.
Secondly, the company’s strategic partnerships with large biopharmaceutical firms and government agencies should provide long-term growth potential. Finally, Cryoport’s financials are strong, with increasing revenue and profits in recent years. Although it may be a good choice for long-term investors, short-term traders should be aware of the stock’s high volatility.
